Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6459d0d1d48a7decbc911d832257e51a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-20 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3687 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0226 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3625 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-36 |
filingDate |
2016-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_766a0a38eb48b1e4545ca45497ab9447 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47976c922c1fc7b3f32f7cfb53f02c29 |
publicationDate |
2017-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2017093147-A1 |
titleOfInvention |
Method for inactivating xenoantigens in biological tissues |
abstract |
A method for inactivating xenoantigens in biological tissues, particularly in tissues that can be used to manufacture bioprosthetic substitutes and/or in bioprosthetic substitutes that are already prepared and intended for human or veterinary clinical use. Such method entails the following steps: - providing a solution based on phenolic compounds, polyphenolic compounds or derivatives thereof, for the inactivation of at least part of the xenogeneic epitopes from such tissues; - incubating the samples to be treated in the various solutions based on phenols/polyphenols in controlled conditions; - subjecting the treated tissues to a series of washes. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020234845-A1 |
priorityDate |
2015-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |